These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology]. Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J; Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665 [TBL] [Abstract][Full Text] [Related]
4. [Dermatological local therapy. How to control eczema]. Niedner R; Iliev D MMW Fortschr Med; 2001 Jun; 143(24):33-8. PubMed ID: 11469016 [TBL] [Abstract][Full Text] [Related]
5. [Topical therapy--risks and unwanted effects]. Zesch A Z Hautkr; 1986 Jun; 61(11):821-3. PubMed ID: 3739399 [TBL] [Abstract][Full Text] [Related]
8. [Percutaneous absorption: topical and systemic treatments]. Machet L; Baïcan A; Pelucio-Lopes C; Patat F; Vaillant L Ann Dermatol Venereol; 1997; 124(6-7):490-6. PubMed ID: 9739917 [No Abstract] [Full Text] [Related]
9. [Hydrocortisone-17-butyrate (0.1 percent) versus hydrocortisone acetate (1 percent) in atopic dermatitis. Controlled double-blind study of 20 children]. Giannetti A; Laria G; Seidenari S Minerva Pediatr; 1981 Jun; 33(12):597-600. PubMed ID: 7022158 [No Abstract] [Full Text] [Related]
10. [Urea in topical therapy of skin diseases--principles and use]. Wohlrab WA Z Arztl Fortbild (Jena); 1993 Aug; 87(8):643-50. PubMed ID: 8379203 [No Abstract] [Full Text] [Related]
11. Initial experience with Natuderm a new skin film emulsion analogue cream. Maisey AR; Brook JH Br J Clin Pract; 1980 Jun; 34(6):178-81. PubMed ID: 7437282 [No Abstract] [Full Text] [Related]
12. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study. Staab D; Pariser D; Gottlieb AB; Kaufmann R; Eichenfield LF; Langley RG; Scott G; Ebelin ME; Barilla D; Schmidli H; Burtin P Pediatr Dermatol; 2005; 22(5):465-71. PubMed ID: 16191004 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics and efficacy of skin medications]. Stüttgen G Hautarzt; 1981 Apr; 32(4):199-207. PubMed ID: 6112211 [TBL] [Abstract][Full Text] [Related]
14. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Förster M; Bolzinger MA; Fessi H; Briançon S Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302 [TBL] [Abstract][Full Text] [Related]
15. [Atopic dermatitis in young skin]. Rev Infirm; 2004 Dec; (106):12-5. PubMed ID: 15672515 [No Abstract] [Full Text] [Related]
16. [Volon A shake mix--a promising innovation]. Brinkmann W Z Hautkr; 1983 Nov; 58(21):1539-41. PubMed ID: 6689239 [TBL] [Abstract][Full Text] [Related]
17. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. de Bruin-Weller MS; Bruijnzeel-Koomen CA Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135 [TBL] [Abstract][Full Text] [Related]
18. Nuclear receptors and unsaturated fatty acids: implications for pharmacologic activity of the galenic forms of topical preparations. Reichrath J Dermatology; 2004; 209(4):348-9. PubMed ID: 15539909 [No Abstract] [Full Text] [Related]